Abcam

Excellence at Abcam, in all aspects of its business, has  underpinned its rapid growth to become a world-class antibody and research tools company. Buchanan has provided PR support to Abcam since its IPO in 2005, since which time Abcam has become one of the most successful companies in the history of AIM.